Prediction of persistence of combined evidence-based cardiovascular medications in patients with acute coronary syndrome after hospital discharge using neural networks

Medical and Biological Engineering and Computing

Volumn 49, Issue 8, 2011, Pages 947-955

  Bourdès, Valérie ^a   Ferrières, Jean ^b,c   Amar, Jacques ^c   Amelineau, Elisabeth ^d   Bonnevay, Stéphane ^e   Berlion, Maryse ^a   Danchin, Nicolas ^f  

^a THEMIS ICTA Group   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c CHU RANGUEIL   (France)

^d BRISTOL MYERS SQUIBB   (United States)

^e Ecole Polytechnique Universitaire   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Acute coronary syndrome; Artificial neural networks; Evidence based medical therapy; Long term persistence

Indexed keywords

ACUTE CORONARY SYNDROMES; ANGIOTENSIN-CONVERTING ENZYME; ANTITHROMBOTIC; ARTIFICIAL NEURAL NETWORK; CORONARY ARTERY BYPASS GRAFTING; GENERAL PRACTITIONERS; HOSPITAL DISCHARGE; HYPERCHOLESTEROLEMIA; LOGISTIC REGRESSIONS; LONG-TERM PERSISTENCE; MEDICAL THERAPY; POSITIVE PREDICTIVE VALUES; PREDICTION ACCURACY; PREDICTIVE ACCURACY; RULE GENERATION;

HEART; HOSPITALS; PATIENT TREATMENT;

NEURAL NETWORKS;

CARDIOVASCULAR AGENT;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CROSS-SECTIONAL STUDY; DRUG ADMINISTRATION; EVIDENCE BASED MEDICINE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; STATISTICS;

ACUTE CORONARY SYNDROME; AGED; CARDIOVASCULAR AGENTS; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PATIENT DISCHARGE;

EID: 79961170069     PISSN: 01400118     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11517-011-0785-4     Document Type: Article

References (36)

1. S Agatonovic-Kustrin R Beresford 2000 Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research J Pharm Biomed Anal 22 717 727 10815714 10.1016/S0731-7085(99)00272-1 1:CAS:528:DC%2BD3cXisFGqsrY%3D (Pubitemid 30193303)
2. RC Ali C Melloni FS Ou K Schmader EM Ohman MT Roe ED Peterson KP Alexander 2009 Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time JAGS 57 1990 1996 10.1111/j.1532-5415.2009.02483.x
3. J Amar J Ferrières JP Cambou E Amelineau N Danchin 2008 Persistence of combination of evidence-based medical therapy in patients with acute coronary syndromes Arch Cardiovasc Dis 101 301 306 18656088 10.1016/j.acvd.2008.04.005
4. D Baldassarre E Grossi M Buscema M Intraligi M Amato E Tremoli L Pustina S Castelnuovo S Sanvito L Gerosa CR Sirtori 2004 Recognition of patients with cardiovascular disease by artificial neural networks Ann Med 36 630 640 15768835 10.1080/07853890410018880 (Pubitemid 40051440)
5. JP Bassand CW Hamm D Ardissino E Boersma A Budaj F Fernández- Avilés KA Fox D Hasdai EM Ohman L Wallentin W Wijns 2007 Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. ESC Guidelines Eur Heart J 28 1598 1660 17569677 10.1093/eurheartj/ ehm132 1:CAS:528:DC%2BD2sXpslKmtLw%3D (Pubitemid 47355992)
6. R Bigi D Gregori L Cortigiani A Desideri FA Chiarotto GM Toffolo 2005 Artificial neural networks and robust Bayesian classifiers for risk stratification following uncomplicated myocardial infarction Int J Cardiol 101 481 487 15907418 10.1016/j.ijcard.2004.07.008 (Pubitemid 40719987)
7. Bourdès V, Bonnevay S, Lisboa PJ, Defrance R, Pérol D, Chabaud S, Bachelot T, Gargi T, Négrier S (2010) Comparison of artificial neural network with logistic regression as classification models for variable selection for prediction of breast cancer patient outcomes. Advances in Artificial Neural Systems 2010, Article ID 309841
8. KF Carruthers OH Dabbous MD Flather I Starkey A Jacob D Macleod KA Fox GRACE Investigators 2005 Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE) Heart 91 290 298 15710703 10.1136/hrt.2003.031237 1:STN:280:DC%2BD2M%2Fot12gsg%3D%3D (Pubitemid 40299203)
9. SS Cross FR Harrison RL Kennedy 1995 Introduction to neural networks Lancet 346 1075 1079 7564791 10.1016/S0140-6736(95)91746-2 1:STN:280: DyaK28%2FisF2huw%3D%3D
10. N Danchin JP Cambou G Hanania Z Kadri N Genès JM Lablanche D Blanchard L Vaur P Clerson P Guéret USIC 2000 investigators 2005 Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry Am Heart J 150 1147 1153 16338251 10.1016/j.ahj.2005.01.058 (Pubitemid 41773515)
11. KA Eagle E Kline-Rogers SG Goodman EP Gurfinkel A Avezum MD Flather CB Granger S Erickson K White PG Steg 2004 Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study Am J Med 117 73 81 15234641 10.1016/j.amjmed.2003.12.041 (Pubitemid 38953725)
12. TA Etchells MJ Harrison 2006 Orthogonal search-based rule extraction for modelling the decision to transfuse Anaesthesia 61 335 338 16548951 10.1111/j.1365-2044.2006.04545.x 1:STN:280:DC%2BD287lvFaisQ%3D%3D (Pubitemid 43740617)
13. TA Etchells PJ Lisboa 2006 Orthogonal search-based rule extraction (OSRE) for trained neural networks: a practical and efficient approach IEEE Trans Neural Networks 17 374 384 10.1109/TNN.2005.863472 (Pubitemid 43380061)
14. EUROASPIRE II Study Group 2001 Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme Eur Heart J 22 554 572 10.1053/euhj.2001.2610 (Pubitemid 32625245)
15. J Feely R Chan J McManus B O'Shea 1999 The influence of hospital-based prescribers on prescribing in general practice Pharmacoeconomics 16 175 181 10539398 10.2165/00019053-199916020-00006 1:STN:280:DyaK1MzptlOmsw%3D%3D (Pubitemid 29450605)
16. Goldberg DE (1989) Genetic algorithms in search optimization and machine learning. Kluwer Academic Publishers, Boston
17. ED Grech DR Ramsdale 2003 Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction Brit Med J 326 1259 1261 12791748 10.1136/bmj.326.7401.1259 (Pubitemid 36688090)
18. S Harder P Thürmann C Thierolf H Klepzig 1998 Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital Int J Clin Pharmacol Ther 36 195 201 9587045 1:STN:280:DyaK1c3ks1CmtQ%3D%3D (Pubitemid 28165623)
19. D Hasdai S Behar L Wallentin N Danchin AK Gitt E Boersma PM Fioretti ML Simoons A Battler 2002 A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 1190 1201 12127921 10.1053/euhj.2002.3193 1:STN:280:DC%2BD38zotFyhtw%3D%3D (Pubitemid 35215245)
20. K Hornik M Stinchcombe H White 1989 Multilayer feedforward neural networks are universal approximators Neural Networks 2 259 366 10.1016/0893-6080(89)90020-8 (Pubitemid 20609008)
21. International Epidemiological Association (IEA). Good Epidemiological Practice (GEP). IEA guidelines for proper conduct in epidemiologic research (2007). http://www.ieaweb.org
22. CA Jackevicius M Mamdani JV Tu 2002 Adherence with statin therapy in elderly patients with and without acute coronary syndromes JAMA 288 462 467 12132976 10.1001/jama.288.4.462 (Pubitemid 34787477)
23. Joint European Society of Cardiology/American College of Cardiology Committee 2000 Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 1502 1513 10.1053/euhj.2000.2305
24. JK Jones L Gorkin JF Lian JA Staffa AP Fletcher 1995 Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population Brit Med J 311 293 295 7633238 1:STN:280:DyaK2MzlvFOrtw%3D%3D
25. HM Krumholz V Vaccarino EF Ellerbeck C Kiefe J Hennen TF Kresowik JA Gold SF Jencks MJ Radford 1997 Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age Am J Cardiol 79 581 586 9068512 10.1016/S0002-9149(96)00819-3 1:CAS:528:DyaK2sXit1WmsLg%3D (Pubitemid 27143158)
26. SP Kulkarni KP Alexander B Lytle G Heiss ED Peterson 2006 Long-term adherence with cardiovascular drug regimens Am Heart J 151 185 191 16368315 10.1016/j.ahj.2005.02.038 (Pubitemid 41815352)
27. HY Lee CE Cooke TA Robertson 2008 Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge J Manag Care Pharm 14 271 280 18439049 (Pubitemid 351711978)
28. F Philippe JP Cambou N Danchin D Thomas 2005 Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice Ann Cardiol Angeiol 54 Suppl 1 S30 S36
29. VS Ramanath KA Eagle 2007 Evidence-based medical therapy of patients with acute coronary syndromes Am J Cardiovasc Drugs 7 95 116 17503881 10.2165/00129784-200707020-00002 1:CAS:528:DC%2BD2sXotV2gs7o%3D (Pubitemid 46790266)
30. CM Roe BR Motheral F Teitelbaum MW Rich 2000 Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization Am J Health Syst Pharm 57 139 145 10688242 1:STN:280:DC%2BD3c7ltV2msg%3D%3D (Pubitemid 30058558)
31. F Rosenblatt 1958 The perceptron: a probabilistic model for information storage and organization in the brain Psychol Rev 65 386 408 13602029 10.1037/h0042519 1:STN:280:DyaG1M%2FjtFCmtw%3D%3D
32. S Silber P Albertsson F Fernandez-Avilès PG Camici A Colombo C Hamm E Jørgensen J Marco JE Nordrehaug W Ruzyllo P Urban GW Stone W Wijns Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology 2005 Guidelines for percutaneous coronary interventions. ESC Guidelines Eur Heart J 26 804 807 15769784 10.1093/eurheartj/ehi564
33. JV Tu 1996 Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes J Clin Epidemiol 49 1225 1231 8892489 10.1016/S0895-4356(96)00002-9 1:STN:280:DyaK2s%2FkslGluw%3D%3D (Pubitemid 26386228)
34. F Van de Werf D Ardissino A Betriu DV Cokkinos E Falk KA Fox D Julian M Lengyel FJ Neumann W Ruzyllo C Thygesen SR Underwood A Vahanian FW Verheugt W Wijns Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology 2003 Management of acute myocardial infarction in patients presenting with ST-segment elevation. ESC Guidelines Eur Heart J 24 28 66 12559937 10.1016/S0195-668X(02)00618-8 (Pubitemid 36109547)
35. R Voss P Cullen H Schulte G Assmann 2002 Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Munster Study (PROCAM) using neural networks Int J Epidemiol 31 1253 1562 12540731 10.1093/ije/31.6.1253 (Pubitemid 36204492)
36. AT Yan RT Yan M Tan T Huynh K Soghrati LJ Brunner P DeYoung DH Fitchett A Langer SG Goodman Canadian ACS Registries Investigators 2007 Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome Am Heart J 154 1108 1115 18035083 10.1016/j.ahj.2007.07.040 (Pubitemid 350123528)